rts logo

Recursion Pharmaceuticals Inc (RXRX) Analysis & Opinions from Experts

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) is -11.05% lower on its value in year-to-date trading and has touched a low of $4.54 and a high of $16.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RXRX stock was last observed hovering at around $9.37 in the last trading session, with the day’s loss setting it -0.6%.

Currently trading at $8.77, the stock is -18.98% and -20.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.81 million and changing -6.40% at the moment leaves the stock -5.91% off its SMA200. RXRX registered 35.97% gain for a year compared to 6-month gain of 14.64%. The firm has a 50-day simple moving average (SMA 50) of $39.03 and a 200-day simple moving average (SMA200) of -$5.57.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -31.54% loss in the last 1 month and extending the period to 3 months gives it a -11.05%, and is -16.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.66% over the week and 7.85% over the month.

Profit margin for the company is -735.99%. Distance from 52-week low is 93.17% and -47.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.59%).

Recursion Pharmaceuticals Inc quarterly earnings per share for the current quarter are estimated at -$0.42 with sales reaching $12.65M over the same period.The EPS is expected to shrink by -9.14% this year, but quarterly earnings will post 26.00% year-over-year. Quarterly sales are estimated to grow 4.30% in year-over-year returns.

Recursion Pharmaceuticals Inc (RXRX) Top Institutional Holders

283 institutions hold shares in Recursion Pharmaceuticals Inc (RXRX), with institutional investors hold 98.06% of the company’s shares. The shares outstanding are 226.26M, and float is at 146.54M with Short Float at 29.70%. Institutions hold 92.41% of the Float.

The top institutional shareholder in the company is Baillie Gifford and Company with over 25.1 million shares valued at $187.48 million. The investor’s holdings represent 12.30% of the RXRX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 11.62 million shares valued at $86.8 million to account for 5.69% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 11.26 million shares representing 5.52% and valued at over $84.11 million, while Kinnevik Ab (publ) holds 5.10% of the shares totaling 10.41 million with a market value of $79.6 million.

Recursion Pharmaceuticals Inc (RXRX) Insider Activity

The most recent transaction is an insider sale by Gibson Christopher,the company’sChief Executive Officer. SEC filings show that Gibson Christopher sold 40,000 shares of the company’s common stock on Mar 28 ’24 at a price of $10.10 per share for a total of $0.4 million. Following the sale, the insider now owns 1.04 million shares.

Recursion Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 28 ’24 that Gibson Christopher (Chief Executive Officer) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Mar 28 ’24 and was made at $10.10 per share for $0.25 million. Following the transaction, the insider now directly holds 0.0 shares of the RXRX stock.

Still, SEC filings show that on Mar 21 ’24, Marriott Tina (President and COO) disposed off 8,000 shares at an average price of $10.75 for $85980.0. The insider now directly holds 639,982 shares of Recursion Pharmaceuticals Inc (RXRX).

Related Posts